OctoWalgreens, CVS, Others Exit Lidoderm Antitrust MDLĮndo Pharmaceuticals has reached an agreement with a handful of big name retailers including Walgreen Co.
#CVS LIDOCAINE PATCH TRIAL#
Can't Dodge Lidoderm Buyers' Antitrust MDLĪ California federal judge Friday squashed attempts by pharmaceutical companies Endo, Teikoku and Watson to end multidistrict antitrust litigation over the Lidoderm pain patch, ruling that there's enough evidence to show that Watson could have beat the other two companies in a patent infringement trial had they not settled. and Kroger Co., told a California federal court Tuesday that they have settled claims against Japanese pharmaceutical company Teikoku and a domestic subsidiary in antitrust multidistrict litigation over the Lidoderm pain patch.
#CVS LIDOCAINE PATCH PATCH#
FebruEndo Settles Rest Of Lidoderm Antitrust SuitĮndo has reached a settlement with the remaining plaintiffs in an antitrust lawsuit over the Lidoderm pain patch on the eve of jury selection for an upcoming trial, court records show, an effort to end the case after a California federal judge refused to enter judgment in its favor.MaEndo, Others Ink $166M Lidoderm Pay-For-Delay Settlementsĭirect purchasers of the Lidoderm pain patch asked for preliminary approval in California federal court Tuesday of pay-for-delay class settlements totaling $166 million reached with branded pharmaceutical makers Teikoku and Endo and generics maker Actavis.JAttys Want $47M From $166M Lidoderm Pay-For-Delay DealĪttorneys for the direct purchasers of the Lidoderm pain patch urged a California federal judge to approve more than $47 million in attorneys' fees and reimbursements out of a $166 million settlement with pharmaceutical companies Teikoku, Endo and Actavis.AugClass Attys Want $39M Cut Of $105M Lidoderm SettlementĪttorneys for end-payors who claimed that pharmaceutical companies delayed the release of a generic form of the Lidoderm pain patch have asked a California federal court to award $38.6 million in fees and expenses for their work securing $104.75 million in settlements with Teikoku, Endo and Actavis, calling it the best comparable outcome in a decade.SeptemTwo Lidoderm Class Action Deals Worth $271M Get Final OKĪ California federal judge on Wednesday approved "excellent" settlements ending claims that Teikoku, Endo and Actavis violated antitrust laws by stalling the release of a generic form of the Lidoderm pain patch, finalizing a $104.75 million deal with end payors and a $166 million deal with direct purchasers, including a combined $85.6 million in attorneys' fees.SeptemClass Attys Get $35M Of $105M Lidoderm Pay-For-Delay DealĪ California federal judge has awarded $35 million in attorneys' fees as part of a settlement for end-payors that claimed a group of pharmaceutical companies delayed the release of a generic form of the Lidoderm pain patch.OctoAllergan's $750M Deal Among Pharma's Top Antitrust PayoutsĪ $750 million settlement this week by Allergan to avert an antitrust trial involving Alzheimer's drug Namenda is among the most eye-popping sums ever shelled out by a drugmaker for allegedly thwarting generic competition.United Food & Commercial Workers International Union.International Association of Fire Fighters.Government Employees Health Association Inc.Class Action, Multi-district Litigation Judge: